Drug Utilisation Sub-Committee utilisation analysis public release documents

10 July 2020 - The utilisation analysis public release documents from the February 2020 Drug Utilisation Sub-Committee meeting are now available. ...

Read more →

Remove the disincentives and biosimilars will flourish, policy expert says

7 July 2020 - Patients could save as much as 17% on out-of-pocket costs if they used biosimilars, but many ...

Read more →

Use of infliximab biosimilar in Medicare population is low but growing

7 July 2020 - Slow growth of use of biosimilar infliximab in a Medicare fee-for-service population suggests lingering hesitancy on the ...

Read more →

Demand for dexamethasone soars after promising findings in UK

27June 2020 - Weekly demand in the U.S. is up more than 600%. ...

Read more →

The impact of drug quality ratings from health technology assessments on the adoption of new drugs by physicians in Germany

15 June 2020 - Payers are increasingly calling for the value of new drugs to be measured explicitly.  ...

Read more →

Looking back, UK patients unhappy with adalimumab biosimilar switch

24 June 2020 - The UK results show how challenging switching to a biosimilar can be, according to patient groups. ...

Read more →

Rising costs explain why Canada is switching to biosimilars

15 June 2020 - Following in the footsteps of British Columbia, other Canadian provinces are working to implement their own biosimilars ...

Read more →

Coverage for biosimilars vs reference products among US commercial health plans

19 May 2020 - The greater use of biosimilars may have the potential to help reduce drug costs.  ...

Read more →

Prescriptions surged as Trump praised drugs in coronavirus fight

25 April 2020 - Prescriptions for two antimalarial drugs jumped by 46 times the average when the president promoted them on ...

Read more →

Principles of ethical prescribing for self and others: hydroxychloroquine in the COVID‑19 pandemic

22 April 2020 - Prescribing medicines with putative benefit for COVID‑19 disease appears very attractive to consumers, clinicians and some senior ...

Read more →

Pharmacists welcome medicine review update

21 April 2020 - Elderly people at risk of medicine-related harm will now have their treatments more regularly reviewed by ...

Read more →

Drug Utilisation Sub-Committee outcome statement

18 March 2020 - The outcome statement from the February 2020 Drug Utilisation Sub-Committee meeting is now available. ...

Read more →

HHS Secretary Alex Azar expresses hope in biosimilar uptake, notes positive momentum

11 March 2020 - HHS Secretary Alex Azar discussed the future of biosimilars in the United States and the actions taken ...

Read more →

PhRMA: federal biosimilar payment policies are having a positive effect

4 March 2020 - Katie Verb, director of policy and research for the biopharmaceutical industry group PhRMA, discusses recent policy changes ...

Read more →

Lyrica, a drug linked to depression and anxiety, now the top pain medication on the PBS

18 February 2020 - Lucy Pallot had never experienced the lows of depression and anxiety until she started taking pregabalin. ...

Read more →